Literature DB >> 17903159

Immediate pathologic effects on the vein wall of foam sclerotherapy.

Camillo Orsini1, Maurizio Brotto.   

Abstract

BACKGROUND: During the past 10 years, sclerotherapy has radically changed, the foam sclerotherapy method being better than that of liquid sclerotherapy.
OBJECTIVES: We have analyzed the immediate pathologic effects on the saphenous vein wall in vivo after sclerotherapy with sodium tetradecyl sulfate (STD) foam.
METHODS: A group of six patients affected by chronic venous insufficiency, operated on by stripping of the saphenous vein, underwent an intraoperative procedure of sclerotherapy to an isolated but not yet removed tract of saphenous vein with 3% STD foam.
RESULTS: The pathologic damage of the foam was extremely rapid with complete damage of the endothelium within the first 2 minutes. In the successive 15 and 30 minutes there was edema of the intimal with its progressive separation from the tunica media and the initial formation and adhesion of the thrombus to the tunica media.
CONCLUSIONS: In this in vivo report we analyze the capacity of 3% STD foam sclerotherapy to damage the saphenous vein wall. The damage is extremely fast and shows the detachment of the intimal and the development of the microthrombus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17903159     DOI: 10.1111/j.1524-4725.2007.33261.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  8 in total

Review 1.  Evolution of Retrograde Transvenous Obliteration Techniques.

Authors:  Mihir Patel; Christopher Molvar
Journal:  Semin Intervent Radiol       Date:  2018-08-06       Impact factor: 1.513

2.  Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Technique and Intraprocedural Imaging.

Authors:  Saher S Sabri; Wael E A Saad
Journal:  Semin Intervent Radiol       Date:  2011-09       Impact factor: 1.513

3.  The Addition of Lipid-Based Contrast Medium does not Inactivate the Detergent Sclerosant Sodium Tetradecyl Sulfate in-vitro.

Authors:  Charlotte L Oliver; Judy Brown; Mike Watkins; Ian McCafferty; Richard J Oliver
Journal:  Cardiovasc Intervent Radiol       Date:  2021-03-11       Impact factor: 2.740

4.  Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia.

Authors:  Holly Boyer; Patricia Fernandes; Chap Le; Bevan Yueh
Journal:  Int Forum Allergy Rhinol       Date:  2015-02-02       Impact factor: 3.858

5.  Foam sclerotherapy for a symptomatic hepatic cyst: a preliminary report.

Authors:  Chihiro Itou; Jun Koizumi; Takeshi Hashimoto; Kazunori Myojin; Tatehiro Kagawa; Tetsuya Mine; Yutaka Imai
Journal:  Cardiovasc Intervent Radiol       Date:  2013-10-30       Impact factor: 2.740

6.  In vitro and ex vivo evaluation of the biological performance of sclerosing foams.

Authors:  Elisabetta Bottaro; Jemma A J Paterson; Luciano Quercia; Xunli Zhang; Martyn Hill; Venisha A Patel; Stephen A Jones; Andrew L Lewis; Timothy M Millar; Dario Carugo
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

7.  Percutaneous aspiration and sclerotherapy of a giant simple hepatic cyst causing obstructive jaundice: A case report and review of literature.

Authors:  Xu-Xia He; Mei-Xing Sun; Ke Lv; Jian Cao; Sheng-Yu Zhang; Jing-Nan Li
Journal:  World J Gastrointest Surg       Date:  2022-07-27

Review 8.  Orbital infarction syndrome after multiple percutaneous sclerotherapy sessions for facial low-flow vascular malformation: A case report and literature review.

Authors:  Weng Sut Sio; Shwu-Huey Lee; I-Chia Liang
Journal:  Indian J Ophthalmol       Date:  2016-08       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.